Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xaria X Li

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|February 13, 2023
TLQP-21 is a low potency partial C3aR activator on human primary macrophagesXaria X Li, John D Lee, Han S Lee, et al.
Biochemical Pharmacology|July 20, 2020
Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and functionXaria X Li, John D Lee, Nicholas L Massey, et al.
The Journal of Biological Chemistry|May 1, 2019
Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1Shubhi Pandey, Xaria X Li, Ashish Srivastava, et al.
ACS Pharmacology & Translational Science|December 20, 2021
Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays <i>In Vitro</i> and <i>In Vivo</i>Declan M Gorman, Xaria X Li, Colton D Payne, et al.
Journal of Medicinal Chemistry|November 11, 2021
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo ActivityDeclan M Gorman, Xaria X Li, John D Lee, et al.
British Journal of Pharmacology|April 27, 2025
Colon-targeted complement C5a<sub>1</sub> receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitisCedric S Cui, Titaya Lerskiatiphanich, Xaria X Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2019
C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanomaJamileh A Nabizadeh, Helga D Manthey, Nadya Panagides, et al.
Cell|October 18, 2023
Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptorsManish K Yadav, Jagannath Maharana, Ravi Yadav, et al.
JCI Insight|May 3, 2019
Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2Faith H Brennan, Trisha Jogia, Ellen R Gillespie, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Structural basis of complement anaphylatoxin receptor activation by an immunostimulant lead candidateAnnu Dalal, Manish K Yadav, Manisankar Ganguly, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 13, 2023
TLQP-21 is a low potency partial C3aR activator on human primary macrophagesXaria X Li, John D Lee, Han S Lee, et al.
Biochemical Pharmacology|July 20, 2020
Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and functionXaria X Li, John D Lee, Nicholas L Massey, et al.
The Journal of Biological Chemistry|May 1, 2019
Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1Shubhi Pandey, Xaria X Li, Ashish Srivastava, et al.
ACS Pharmacology & Translational Science|December 20, 2021
Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays <i>In Vitro</i> and <i>In Vivo</i>Declan M Gorman, Xaria X Li, Colton D Payne, et al.
Journal of Medicinal Chemistry|November 11, 2021
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo ActivityDeclan M Gorman, Xaria X Li, John D Lee, et al.
British Journal of Pharmacology|April 27, 2025
Colon-targeted complement C5a<sub>1</sub> receptor inhibition using pH-sensitive nanoparticles ameliorates experimental colitisCedric S Cui, Titaya Lerskiatiphanich, Xaria X Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2019
C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanomaJamileh A Nabizadeh, Helga D Manthey, Nadya Panagides, et al.
Cell|October 18, 2023
Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptorsManish K Yadav, Jagannath Maharana, Ravi Yadav, et al.
JCI Insight|May 3, 2019
Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2Faith H Brennan, Trisha Jogia, Ellen R Gillespie, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Structural basis of complement anaphylatoxin receptor activation by an immunostimulant lead candidateAnnu Dalal, Manish K Yadav, Manisankar Ganguly, et al.
Pageof 3